Lynnsey and Matthew are joined by Neal Goodwin and Pawel Krysiak of Jaya Bio, a preclinical life sciences company developing gene therapies for genetically defined neurodegenerative diseases. They share how their team is using precision medicine to target specific mutations linked to Alzheimer’s, Parkinson’s, and frontotemporal dementia, aiming to arrest disease progression with a single dose. Our conversation explores how gene therapy works, what makes Jaya Bio’s approach different, and more. Tune in now!
The cost and pricing of pharmaceuticals are matters of substantial scrutiny. In March 2025, a jury in an Illinois federal court decided in favor of a pharmacy chain that its false claims for medica...